L2: normal kidney structures
	main:
	
L3: the glomerulus & GFR
	main:
	- GFR = Ucr * V / Pcr
	- hormonal GFR regulation
		- angiotensin II:
			- constricts efferent -> ΔP increases, GFR same, RBF decreases, π increases -> FF increases
			- increases PCT Na reabsorption
		- ANP:
			- dilates afferent -> ΔP increases, GFR increase, RBF increased, π same, -> FF variable, decreased
		- norepinephrine:
			- constricts efferent + afferent -> ΔP same, GFR decreased, RBF decreases, π same -> FF same

	
L4: estimation of renal function
	main:
	
L5: the tubule & tubular function
	main:
	- tubule components:
		- 70% Na/H20 reabsorption
		- 90% H2CO3 reabsorption
		- proximal convoluted tubule (PCT):
			- activity increased by ATII
			- Na/H exchanger
				- reabsorbs Na
				- reabsorbs H2CO3
				- inhibited by diamox
			- Na/solute co transporters
				- oats inhibited by probenecid
				- inhibited by flozins
	
	- loop of henle:
		- descending limb:
			- water reabsorption
		- thick ascending limb:
			- NKCC
				- reabsorbs Na, K, 2 Cl
				- inhibited by loop diuretics
			- Ca, Mg, NH4 reabsorbed by gradient
			- K excreted by ROMK

	- distal convoluted tubule:
		- TSC NaCl co-transporter
			- inhibited by thiazides
		- Ca / Na exchanger
			- reabsorbs Ca
			- slowed by high cell Na -> thiazides cause hypercalcemia
	
	- collecting ducts:
		- intercalated cells:
			- H+ ATPases -> H2CO3 reabsorption
			- stimulated by MR / aldosterone
			- large pH gradient established by tight junctions

		- principal cells:
			- ENaC
				- Na reabsorption
				- K channel to excrete K / offset charge
				- inhibited by amiloride
				- stimulated by MR / aldosterone
		
		- aquaporins:
			- stimulated by ADH / vasopressin
			- 


L6: kidney development
	main:
	- fetal urine:
		- urine products supplment amniotic fluid
		- fetal kidney disfunction -> pulmonary hypoplasia
	- low birth weight -> kidney issues
	- congenital anomalies of the kidney + urinary tract (CAKUT):
		- detected by fetal ultrasound
		- causes 50% of pediatric kidney failure

		- types:
			- renal agenesis: UB failed to reach MM
			- duplication of urinary track: gain of function
			- primary vesicoureteral reflux (VUR):
				- retrograde urine
				- SLIT2 / ROBO2
				- XY babies
				- prenatal US
			- secondary VUR: elevated bllader pressure
	- renal-coloboma syndrome:
		- PAX2
		- optic nerve cysts, pupillary fissure, mesangial fibrosis
		- dominant


L7: volume regulation
	main:
	- afferent volume senses:
		- intrathoracic: LA, RA, RV, pulmonary capillaries
		- aterial: carotid + aortic arch
		- renal: juxtaglomerular apparatus (JGA)
		- CNS: volume receptors
		- hepator volume receptors

	- hormonal response to volume depletion:
		- pathway:
			- decreased renal perfusion
			- lower Cl to macula densa in TALH via NKCC
			- macula densa increases COX2 -> PGE2 release
			- PGE2 causes JGA/granular cells to release renin
			- renin converts ATogen -> AT
			- ACE in lung capillaries ATI -> ATII
			- ATII -> increased Na/H2O reabsorption
			- ATII -> increases aldosterone, ADH, thirst

	- primary volume depletion:
		- symptoms: light headed, weak/tired, cold, thirsty
		- signs: low BP, orthostasis, weight loss, dry skin, no saliva, low skin turgor
		- labs: high BUN/Cr, low Una, high Uosm, low V
		- physiology:
			- aldosterone -> ENaC Na recovery -> low Una
			- aldosterone -> K secretion -> increased UK
			- ADH -> AQP2 increased -> low V
			- ADH -> NKCC increase -> high Uosm
		- diagnosis:
			- Pcr ~ 1.3 - 2
			- BUN high (> 10)
			- BUN/Cr > 20
			- low FeNa ~ Una / Pna
			- high ADH

	- effective volume depletion:
		- primary gain of Na
		- causes: CHF, cirrhosis, nephrosis
		- signs/symptoms:
			- stage I: same as primary volume depletion
			- stage II: normalized

	- volume overload:
		- gain of Na or IV overload or redistribution
		- signs: dyspnea, high BP, weight gain, edema, dilute urine

	- addisons disaes:
		- adrenal insufficiency
	
	
L8: derangements in body volume
	main:
	- body water:
		- 1/3 extracellular
			- 1/3 vascular
			- 2/3 interstitial
		- 2/3 intracellular
	
L9: blood pressure regulation
	main:

	- pressure-natriuersis theory:
		- high BP to excrete more Na
	
	- treatments:
		- dietary Na:
			- biggest effect on resistant htx (23/9)
		- thirsty gene:
			- low salt: low BP and high RAAS
			- salt + high RAAS: BP increases
		- dysfunctional gastro-renal axis
			- 

L10: secondary hypertension
	main:
	- MC4R -> obesity
	- glucorticoid remediable aldosteronism (GRA):
		- dominant
		- stroke + CV events

	- AME:
		- 11-B hydroxysteroid dehydrogenase 2 dysfunction
			- enzyme that converts cortisol -> cortisone
			- inhibited by glycyrrhizic acid (licorice)
		- excess cortisol
		- recessive
		- hypokalemia, metabolic alkalosis, suppressed renin + aldosterone

	- primary aldosteronism:
		- 40% are adrenal adenomas: CONN + cushing syndrome
		- 60% are bilateral hyperplasia: repond to MRA


	- renal artery stenosis:
		- decreased perfusion -> increased RAAS
		- dx w/ CT angio, duplex doppler, MR angio
		- medial fibromuscular dysplasia:
			- string of beads CT angio
			- small kidney
			- tx: angioplasty
		- atherosclerosis:
			- tx: angioplasty + stent

	- pheochromocytoma
		- anxiety, dizziness, headaches, sweating, palpitations
		- episodic high BP, orthostasis
		- elevated catecholamine metabolites
		- rules of 10:
			- 10% extra-adrenal, malignant, bilateral, no htx
			- 40% genetic

	- hypotensive disorders:
		- signs:
			- metabolic alkalosis
			- hypokalemia
			- elevated renin
			- elevated aldosterone

		- recessive
		- gitelman syndrome:
			- loss of NCCT, thiazide transporter
			- hypocalciuria

		- bartter syndrome:
			- NKCC, ROMK, CLCNKB loss, loop diuretic resemblance
			- hypercalciuria


L11: antihypertensive therapy
	main:
	- stages:
		- normal: <120 / <80
		- prehypertension: 120-129 / <80
		- htx stage 1: 130-139 / 80-89
		- htx stage 2: >140 / > 90
		- hypertensive crisis: >180 / >120
	
	- measuring:
		- whitecoat htx: 5-65%
		- masked htx: 14-30%
		- measure over 24 hours

	- types:
		- primary
		- secondary:
			- types:
				- pheochromocytoma
				- hyperaldosteronism
				- hyperthyroidism
				- cushings syndrome
				- renovascular disease
				- renal parechymal disease
				- OSA
				- meds
			- work up if:
				- severe htx: >170 / > 110
				- acute rise
				- htx before puberty
				- before age 30 in non-obese
	- treatment:
		- diet modifications
			- low salt: 5-20 / 3-9 reduction
			- vegetarian: 5 / 2 reduction
				- more fat -> more salt
		- exercise: moderate: OR .90, high: OR .8
		- black barbershops: BP decrease ~9 from health promotion, ~27 from tx + health promotion
		- diuretics: thiazides, loops, K-sparing
		- RAAS blockers: ACEi, ARBs, renin inhibitors, MRAs
		- CCBs: both dihydropyridine and non
		- direct vasodilators
		- adrenergic inhibitors: cental α agonists, α/β blockers

		- paradigms:
			- high salt: diuretics
			- high RAAS: RAAS blockade
				- low PRA: anti-volume = ARBs, thiazides, CCBs, α blockers 
				- high PRA: anti-renin:
					- r1 RAAS blockers: ACEi, ARBs, DRIs
					- r2 renin suppresants: β blockers, central α agonists, reserpine
			- high sympathetic:
				- identifiers:
					- stroke, OSA, alcoholism, paroxysmal htx
					- refractory htx
					- unexplained severe htx
					- htx + sinus tachycardia
			- use combo therapy!
			- chronotherapy, > 1 med at night!

			- special cases:
				- CAD: β blockers, ACEi
				- CKD: ACEi/ARBs, diuretics
				- 
			- hypertensive urgency:
				- BP > 180 / > 100
				- no signs / symptoms
				- tx: oral therapy, bring to 160/100 in 24-48 hours, <130/80 over 8 weeks
			
			- hypertensive emergency:
				- signs + symptoms:
					- ICP, stroke, seizure,
					- retinal hemorrhages, exudates, papilledema
					- pulm edema, angina, MI, dissection, CHF
					- ARF w/ increased Cr, proteinuria, hematuria
				- tx: hospitalization
					- IV therapy DBP -> 100 in 2-6 hours
					- 25% reduction in 2-6 hours
					- overaggresive -> relative hypotension -> ischemia
					- <130/80 on oral therapy over 2-3 mo
				- meds:
					- oral: captopril, nifedipine, clonidine
					- IV:
						- vasodilators: hydralazine, nitroprusside, fenoldopam, nitroglycerin, enalaprit
						- adrenergic inhibitors: labetalol, esmolol, phentolamine



L12: osmolality
	main:
	- body: 290 mOsm/L

	- ADH:
		- osmotic release:
			- 290 mOsm water resorption is maximal
			- vasopressin after 290 mOsm -> continue to drive thirst
			- separate from sodium regulation
		- non-osmotic release:
			- ADH from other sources
			- JGA + baroreceptors -> ADH release

	- osmolar maintenance:
		- intake = 600 mOsm/day
		- max urine dilution = 50 mOsm/L
		- max V = 12 L/day
		- max urine concentration = 1200 mOsm/L
		- min V = .5L/day


L13: derangements in tonicity
	main:
	- tonicity is behavior of solution

	- hypernatremia:
		- acute:
			- osmotic demyelination
			- central pontine myelinolysis
		- causes:
			- water deficit
			- salt intoxication
			- non-renal water loss
			- renal water loss: osmotic diuresis, diabetes insipidus (DI)

		- diagnosis:
			- renal: polyuria -> check Uosm
				- <250: DI
				- > 300 solute diuresis: DM, mannitol
			- extrarenal: GI, sweat, respiratory, burns

		- adaptation:
			- chronic hypernatremia -> idiogenic osmoles prevent water loss

		- tx:
			- free water deficit (FWD): TBW * ([Na+] / 140 - 1)
				- TBW = weight * TBW_factor:
					- male/child: .6
					- female/old male: .5
					- old female: .45
				- add 24h insensible losses

			- severe symptoms: 3-5% reduction in Na is enough
			- mild: faster in adults, slower in children



	- hyponatremia:
		- acute:
			- cerebral edema
			- uncal herniation
			- seizures, coma, stupor
		- iso-osmolar:
			- high lipids / protein
		- hyper-osmolar:
			- unmeasured solutes
		- hypo-osmolar:
			- increased free water intake
				- primary polidisia, water intox
				- ADH absent, Uosm low
			- decreased free water excretion
				- renal failure
				- normal ADH:
					- volume depletion
					- sense volume depletion:
						- czCHF, cirrhosis
						- high risk of death
					- renal/cerebral salt wasting
				- elevated ADH: SIADH
				- special:
					- NSAIDS: PG antagonize ADH effect on tubules
					- thiazides: cannot make dilute urine
					- adrenal insufficiency: salt wasting + hypotension + CRH -> ADH
					- low oSm intake: tea  + toast, beer potomania
			-  tx:
				- 4-6 meq correction then slow
				- emergency: 100 ml 3% saline IVP
				- ΔPNa = (infusate Na - PNa) / (TBW + 1)


	- extracellular osmolality:
		- regulated by Na
	- intracellular osmolality:
		- regulated by K

	
L14: acid base homeostasis
	main:
	- pH: 7.37 - 7.43

	- HCO3 reabsorption / H+ secretion:
		- proximal tubule:
			- Na/H exchanger
			- Na/CO3 co-transporter
			- stimulated by ATII
			- 90% reabsorption of H2CO3
		- collecting duct:
			- intercalated cells:
				- H+ ATPase
				- Cl/HCO3 exchanger
				- 10% reabsorption of H2CO3
				- additional creation of H2CO3
				- responds to:
					- aldosterone
					- pH gradient
					- K: 
					- NH3: net acid production
					- pCO2: CO2 stimulates exocytosis of H+ ATPases vesicles

	- acidosis:
		- respiratory: high CO2
		- metabolic: reduced HCO3 production

	- alkalosis:
		- respiratory: low pCO2, low HCO3
		- metabolic: high pCO2, high HCO3


L15: acid base disorders
	main:
	- normal bicarb 22-29
	- carbonic anhydrase is key converting enzyme
	- acid balance:
		- 1st: buffers
		- 2nd: compensation
			- moves pH towards normal but never norma

	- anion gap:
		- AG = cations - anions = Na - (Cl + HCO3)
		- normal ~ 8-12
		- indicates other anions in blood: mostly albumin
		- loss of HCO3- w/ increase in Cl -> No anion gap change
		- gain of H+ + anion -> anion gap increase

	- acidosis:
		- metabolic:
			- H+ gain or HCO3- loss
			- increase ventilation "blow off acid" -> pCO2
			- response:
				- bone buffering: HCO3- + CO32- release 
				- increase minute ventilation
				- H+ shift into cells
				- proximal tubular ammoniagensis: adds HCO3- to blood and NH3/4 to urine
			- causes:
				- increased anion gap:
					- lactic acid, renal failure, ketoacidosis
					- methanol, aspirin, glycol, rhabdomyolysis
				- normal anion gap:
					- diarrhea (HCO3- loss), intestinal fistula, tube feeds, renal failure
					- RTA 1, 2, 4, resuscitation acidosis (saline admin)

		- lactic acidosis:
			- shock, cardiac arrest, sever hypoxemia
			- general tonic-clonic seizure
			- salicylate, cyanide
			- non-reverse transcriptase inhibitors for HIV
			- respiratory alkalosis
			- severe acute or chronic liver disease: decreased lactate clearance
			- lymphoma
			- metformin

		- ketoacidosis:
			- increased free fatty acids (FFA)

		- renal failure:
			- GFR < 25
			- non-anion gap: impaired H+ excretion
			- anion gap: impaired sulfate + H+ excretion

		- renal tubular acidosis:
			- normal AG: impaired HCO3- reabsorption or H+ excretion

			- RTA 1:
				- distal tubule
				- defective H+ ATPase
				- impaired gradient: causes hypokalemia
				- high urine pH > 5.5

			- RTA 2:
				- proximal tubule
				- any H+ transporters: example Na/H+ transporter
				- HCO3 wasting
				- fanconi syndrome:
					- large part of proximal tubule impaired
					- impaired absorption of AAs, glucose, Pi, etc
					- high Uglucose, low serum PO4, high FePO4
					- low Puric acid, low vitamin D -> bone disease

				- acetazolamide inhibits CAII -> RTA 2
				- Na reabsorption compensated in collecting duct -> hypokalemia
				- urine pH < 5.5 once serum HC03 is reduced to 17/18

			- acidosis respiratory compensation:
				- expected pCO2 = 1.5 * [HCO3-] + 8 +/- 2
				- if pCO2 < epCO2: superimposed respiratory alkalosis, increased breathing
				- if pCO2 > epCO2: superimposed respiratory acidosis, decreased breathing
		
		- respiratory:
			- increased pCO2
			- acute: eHCO3 = normal + (pCO2 - 40)
			- chronic: eHCO3 = normal + 5 * (pCO2 - 40)
			- HCO3 > eHCO3: superimposed metabolic alkalosis
			- HCO3 < eHCO3: superimposed metabolic acidosis

	- alkalosis:
		- metabolic:
			- causes:
				- loss of H+ or gain of HCO3-:
					- loss of H+:
						- loop or thiazide diuretics
						- vomiting, barter/gitelman syndromes, excess sweating
					- gain of HCO3-:
						- calcium alkali syndrome: increased Ca + HCO3-
						- IV Na2CO3
				- AND
				- decreased HCO3- excretion
					- extracellular fluid depletion
					- hyperaldosteronism: increased H+ secretion
					- hypokalemia: stimulates ammoniagensis + H+ secretion -> increased serum HCO3

			- post hypercapnea:
				- compensated hypercapnea (high HCO3) -> acute pCO2 drop (on vent) -> high HCO3 causes alkalosis
			
			- alkalosis respiratory compensation:
				- epCO2 = 0.7 * [HCO3] + 20 +/- 5
				- if pCO2 < epCO2: superimposed respiratory alkalosis, increased breathing
				- if pCO2 > epCO2: superimposed respiratory acidosis, decreased breathing
		
		- respiratory:
			- decreased pCO2
			- acute: eHCO3 = normal - 2 * (40 - pCO2)
			- chronic: eHCO3 = normal + 5 * (40 - pCO2)
			- HCO3 > eHCO3: superimposed metabolic alkalosis
			- HCO3 < eHCO3: superimposed metabolic acidosis


L16: potassium homeostasis
	main:
	- dietary K greatly affects serum K
		- excreted within hours
	- K shifts:
		- into cells:
			- epinephrine
			- insulin
			- alkalosis
		
		- out of cells:
			- acidosis
			- diabetes
			- β blockers

	- K homeostasis:
		- intracellular absorbtion
		- excretion:
			- 95% reabsorbed in PCT + TALH
			- UK is dependent on distal tubule + collecting duct secretion
			- collecting duct:
				- principal cells:
					- K gradient affects ENaC:
		- channels:
			- ROMK: small conductance
			- BK: large conductance, Ca sensitive
				- expressed in principal + intercalated
				- flow dependent: Ca increase due to flagella

		- secretion regulation:
			- aldosterone:
				- increases ROMK
				- increases ENaC -> more negative membrane potential -> higher K secretion
				- increases Na/K ATPase
			- urine flow rate:
				- low K tubular fluid
				- increased Ca -> opens BK -> increased K secretion
			- acid/base balance:
				- acidosis -> low intracellular K
				- alkalosis -> high intracellular K
	
	- hypokalemia:
		- causes:
			- decreased intake
			- re-distribution:
				- alkalosis
				- insulin infusion
				- β-adrenergic agonists: asthma (SABA/LABA)

			- increased loss:
				- non-renal: diarrhea, sweat
				- renal:
					- increased flow rate: diuretics
					- hyperaldosteronism
					- drugs: amphotericin B

			- genetic:
				- glucorticoid remediable aldosteronism (MRA): CYP11B2 + 11B1
				- liddle syndrome: ENaC mutation
				- bartter's syndrome: NKCC or Cl channel mutation
				- apparent mineralocorticoid excess: steroid dehydrogenase
				- adrenal adenomas: CLCN2, KCNJ5, CACNA1H
				- hypokalemic periodic paralysis: NaV1.4 channel

		- symptoms:
			- muscle weakness -> paralysis
			- sometimes rhabdomyolysis
			- EKG: U waves


	- hyperkalemia:
		- causes:
			- intake: only if acidosis or renal failure
			- re-distribution:
				- acidosis
				- diabeteas mellitus
				- β-adrenergic blockers

			- decreased renal excretion:
				- decreased urine flow rate: CHF, oliguric ATN
				- hypoaldosteronism: ACEi, ARBs
				- drugs: ENaC blockers, amiloride, triamterene
				- interstitial renal disease

			- genetic:
				- infantile hyperkalemia: ROMK
				- pseudohypoaldosteronism:
					- type IA: mineralocorticoid receptor
					- type IB: inactivating ENaC
					- type II: gordon syndrome, ROMK mutations
				- periodic paralysis: NaV1.4 channel
		
		- symptoms:
			- EKG: peaked T waves

	- bartter's syndrome:
		- mimics loop diuretics
		- hypovolemic
		- high renin, high aldo
		- metabolic alkalosis, 
		- hyperkalemia mutations:
			- ROMK
			- CaSR: Ca sensing receptor
		- hypokalemia mutations:
			- NKCC
			- CLC-KB: chloride channel
			- barrtin: Cl channel protein
		

L17: diuretics
	main:
	- loop:
		- block NKCC in TALH
		- 25% Na
		- types:
			- furosemide
			- bumetanide
			- torsemide
			- ethacrynic acid

		- effects:
			- hypokalemia: causes are increased flow + increased aldo
			- hypocalcemia
			- metabolic alkalosis:
				- more H+ secretion in collecting duct to reabsorb Na
		
	- thiazide:
		- block Na/Cl co-transporter in DCT
		- 5% Na
		- types:
			- hydrochlorothiazide
			- chlorthalidone
			- metolazone

		- effects:
			- hypokalemia
			- hypercalcemia
			- metabolic alkalosis
			

	- K-sparing:
		- 2% Na
		- types:
			- ENaC blockers:
				- amiloride
				- triamterene
			- MR blockers:
				- spironolactone
				- eplerenone
		- effects:
			- hyperkalemia
			- metabolic acidosis: reduced ENaC -> reduced gradient -> less H+ secretion

	- carbonic anhydrase (CAII) inhibitors:
		- PCT CAII:
			- prevents HCO3 production
			- CAII allows H+ reabsorption -> stops Na/H+ ATPase
		- types:
			- acetazolamide
		- effects:
			- metabolic acidosis: reduced HCO3- reabsorption
			- hypokalemia: 

	- osmotic:
		- osmotic pressure pulls H20 from PCT + descending limb
		- removes free water
		- types:
			- mannitol
			- urea
			- glucose

	- diuretic adjustment/resistance:
		- increased RAAS -> distal hypertrophy
		- loop diuretics increase Na/Cl co-transporter abundance (aldo)
		- tx:
			- combo therapy
			- increase dose
			- Na restriction

	- use cases:
		- SIADH: loop
		- hypercalcemia: loop
		- calcium stones: thiazides
		- loop-diuretic induced metabolic alkalosis: acetazolamide or K-sparing
		- loop-diuretic induced hypokalemia: K-sparing


L18: urinalysis
	main:
	- physical:
		 - color:
		 	- red: hematuria, hemoglobinuria or	myoglobinuria
		 	- white: chyluria, propofol, phosphate crystals
		 	- brown: red, jaundice, chloroquine, nitrofurantoin
		 	- green: methylene blue, triamterene, propofol
		 	- black: alkaptonuria
		 	- pink: mild red, uric acid crystals
		 - turbidity: non-transparent: infection, genital secretions, chyluria, crystals
		 - odor:
		 	- foul: infection
		 	- maple syrup urine disease
		 	- musty: phenylketonuria
		 	- sweet/fruity: ketones

	- chemical:	

	
L19: acute kidney injury
	main:
	- acute tubular necrosis:
		- ischemia
		- high UNa, high FeNa, low BUN/Cr
		- Uosm = Sosm
		- low V or normal V
		- urinalysis: muddy-brown granular casts
		- histology:
			- dilated tubular lumens
			- loss of brush border
			- normal glomeruli

		- causes:
			- constrast
			- rhabdomyolysis

	- pre-renal:
		- low Una, low FeNa, high BUN/Cr
		- low Uosm, low V
		- urinalysis: hyaline "ghost" casts
		- histology: normal

	- post renal

	- causes:
		- CHF, portal htx

	- pathophysiology:
		- necrotic tubules -> impaired reabsorption (low Cl) -> afferent vasoconstriction -> decreased GFR

	- effects:
		- uremia:
			- accumulation of organic waste

		- anemia, hyponatremia, hyperkalemia, hypocalcemia
		- volume overload, hypoxia

	- tx:
		- monitor, treat primary


L20: fluid and electrolyte therapy
	main:
	- fluid destinations:
		- cystalloids: extracellular
			- saline
			- dextrose + saline combo
			- balanced: plasmalyte, ringer's lactate (RL)
				- help w/ renal perfusion
		- dextrose: everywhere
			- DXW
		- colloids + blood: intravascular
			- albumin 5% + NS
			- albumin 25%
			- dextrans
			- hetastarch

	- fluid deficits:
		- intravascular:
			- causes: hemorrhage
			- signs: cardio effects, cool, sweating, dry mucus membranes

		- extracellular:
			- causes: salt + water loss, sepsis
			- signs: skin turgor, sunken eyeballs, weight, hemo
		
		- total:
			- causes: diabetes insipidus, osmotic diarrhea
			- signs: thirst, hypernatremia
			- water deficit:
				- defict = weight * (PNa / Pna desired - 1) * .6 M / .5W
	

L21: nephrotic syndrome I + II
	main:

	- nephrotic syndrome:
		- heavy albuminuria: > 3-3.5 g/day
		- hypoalbuminemia: proteinuria + increased albumin catabolism
		- edema: low oncotic pressure
			- tx: low Na diet, loop diuretics
		- hyperlipidemia: maltese crosses
			- tx: statins
		- thrombotic tendency:
			- tx: sometimes anticoagulation

		-tx:
			- treat principal
			- slow progression + reduce proteinuria:
				- bp regulation
				- ACEi/ARBs, SGLT2i

		- types:
			- minimal change disease (MCD):
				- pathology:
					- lipoid nephrosis: pale, fatty kidneys
					- lipids in PCT: fatty tubules
					- urinalysis: oval fat body
					- LM: normal glomeruli
					- EM: podocyte effacement
					- no Ig or C immunoflourescence

				- physiology:
					- effacement of podocyte
					- thickening of podocyte, no gaps
					- viral infections/immunizations/hodgins disease may precede
					- increased lymphocytotoxins: permeability factors/cytokines, antibody to nephrin

				- diagnosis:
					- 10% NS in adults
					- 85% NS in children
					- sudden onset of heavy proteinuria + edema
				- tx:
					- steroids
					- low salt diet + loop diuretics

				- symptoms:
					- edema, high proteinuria
					- hypoalbuminemia, high cholesterol

			- focal segmental glomerulosclerosis (FSGS):
				- pathology:
					- subset of glomeruli (focal) + segment of glomerular tuft (segmental)
					- silver stain: focal segmental darkening
					- IF: segmental staining for IgM + C3
					- EM: podocyte effacement + detachment
					- progression: interstitial fibrosis + tubular atrophy

				- symptoms:
					- edema + weight gain
					- 4+ albuminuria
					- low seron albumin
					- very high proteinuria
					- negative serologies
					- hypercholesterolemia
					- no improvement with steroids

				- causes:
					- primary: unknown
					- secondary:
						- genetic: nephrin, podocin
						- HIV: tubular microcysts in HIVAN
						- covid: glomerular tuft collapse
						- heroin, anabolic steroids
						- adaptive cause to elevated GC pressure
							- reflux nephropathy, renal agenesis, CRD
					- risks:
						- APOL1: prevents sleeping sickness

				- physiology:
				- diagnosis / epidimiology:
					- >20% idiopathic NS
					- 70% NS adults, 1/3 proteinuria
					- 50% get renal dysfunction
					- worse symptoms -> predict ESRD
					- 50% remission after immunosuppression
					- recurs in 1/3 transplant kidneys

				- tx:


			- membranous glomerulopathy (MGN):
				- pathology:
					- GBM thickening
					- no hypercellularity
					- silver stain: GBM spikes, thick blackening of GBM
					- trichrome: red subepithelial deposits
					- IF: granular IgG + C3, entire glomeruli
					- IF: PLA2R staining
					- EM: dense subepithelial deposits separated by GBM spikes
					- EM: podocyte effacement

				- symptoms:
					- edema
					- low serum albumin
					- hypercholesterolemia
					- high proteinuria
					- increased thrombosis - RVT common

				- physiology:
					- antibodies deposit subepithelials against Ag
					
					primary: antibody to PLA2R 70% of MGN
					secondary:
						- antigens: hep B, hep C, syphilis, malaria, schistosomiasis
						- antigens: gold, penicillamine, collagen vascular disease, carcinoma

				- diagnosis:
					- most common NS in white adults
					- 1/3 -> spontaneous remission
					- 1/3 -> persistent NS
					- 1/3 -> ESRD

				- tx:
					- cyclosporine
					- rituximab
					- alternate steroids - cytotoxics
					- anti-PLA2R levels show response before proteinuria
					- anti-PLA2R levels predictive of outcome

			- diffuse diabetic glomerulosclerosis:
				- pathology:
					- H&E: diffuse thickening of mesangium
					- trichrome: glomerular microaneurysm
					- EM: thick gbm + mesangial sclerosis
					- EM: mesangial nodules

				- symptoms:
					- proteinuria
					- elevated Cr
					- edema + weight gain

				- physiology:
					- thickening in capillary, microvessel BMs
					- thickening in renal tubules, mammary ducts, schwann cells
					- high plasma proteins -> mesangial sclerosis
					- low sialic acid content -> proteinuria + GBM degradation
					- GBM degradation -> GBM thickening

				- diagnosis:
					- large kidneys w/ ESRD
				
				- tx:
					- BP regulation
					- ACEi/ARBs: less GC pressure -> less scarring
					- SGLT2i: higher NaCl delivery to macula densa -> less GC pressure -> less scarring
					- blood glucose control

			- amyloidosis nephrotic syndrome:
				- pathology:
					- H&E: amyloidosis, homogenous global segmental mesangium thickening
					- congo red: orangiophilia of mesangium
						- polarization -> apple green birefriengence, global + segmental

					- EM: amyloid fibrils
					- immunostain for SAA -> AA amyloid
					- IF: lambda light chain stain: all mesangium 
					- gross: white pale, large

				- symptoms:
					- rheumatoid
					- edema, proteinuria, normal BUN, normal Cr
					- negative serologies
					- GFR = normal

				- physiology:
					- types:
						- AL: 
							- primary
							- light chains
							- cause: dysproteinemia
						- AA: 
							- secondary
							- serum amyloid A (SAA) protein
							- cause: inflammation / infection
								- all the chronic infections / inflammations

				- diagnosis:
				- tx:
					- diuretics
					- ACEi / ARBs
					- TU

	
L23: glomerulonephritis I + II
	main:
	- lesion naming:
		- focal: <50% glomeruli
		- diffuse: ≥50% glomeruli
		- segmental: part of glomerulus
		- global: full glomerulus

	- acute nephritic syndrome:
		- renal failure, htx, hematuria
		- urinalysis: 
			- RBCs, sometimes deformed: acanthocytes (loops)
			- RBC casts: look like logs
			- variable albuminuria 

		- mechanisms:
			- linear: Ab to glomerular Ag
			- granular:
				- glomerular Ag-Ab complex deposits
				- antigen is implanted in glomerular capillary wall -> Ag-Ab complex

			- fix complement on GBM + attract PMN

			- glomerular proliferation patterns:
				- endocapillary: within glomerular tuft
					- leukocytes, endothelial cells, mesangial cells
				- crescentic: extracapillary
					- parietal epithelial cells

	- rapidly progressive glomerulonephritis:
		- causes:
			- anti-GBM: check anti-GBM Abs
				- tx: steroids, cyclophosphamide, plasmapheresis

			- immune complex GN (LN, IgAN, PSGN): check complement, ANA
				- tx: TU

			- pauci-immune GN: check ANCA
				- cyclophosphamide, rituximab, steroids

	- acute post-infectious glomerulonephritis:
		- pathology:
			- diffuse, global endocapillary proliferation
			- glomerular neutrophil invasion
			- trichrome: red humps on GBM
			- EM: large dense subepithelial humps outside GBM
			- EM: podocyte effacement over humps
			- EM: RBCs going through GBM gaps
			- IF: granular IgG + C3 -- starry sky pattern
			- gross:
				- acute: red dotted "flea bitten" kidney
				- chronic: leath grain, granular

			- progression: tubular atrophy + interstitial fibrosis
				- chronic: depressions + elevations

			- if from endocarditis: usually focal + segmental

		- symptoms:
			- dark urine, low V
			- edema, high BP
			- urinalysis: rbcs, rbc casts, 2+ proteinuria
			- high Pcr, low complement, C3 low, ASLO high

		- physiology:
			- infection related antigens
				- usually group A beta-hemolytic streptococcus 
				- strep: pyrogenic exotoxin B

		- diagnosis:
			- children > adults
			- 10-14 days post infection
			- low C3 + complement
			- positive serology for recent infection (strep s)
			- <2% rapidly progress to crescents -> poor prognosis

		- tx:
			- resolve ~6 weeks

	- IgA nephropathy + henoch schonlein purpura:
		- pathology:
			- >3 mesangial cells
			- diffuse mesangial proliferation
			- IF: mesangial IgA
			- EM: large mesangial deposits + RBCs in urinary space

		- symptoms:
			- dark brown urine
			- urinalysis: rbc + rbc casts
			- mild proteinuria
			- normal serologies + complement

		- physiology
			- IgA deposts in mesangium
			- defective hepatic clearance: cirrhosis
			- increased IgA production: elevated serum IgA, post URI/GE
			- defective galactosylation of IgA hinge region
			- systemic disease -> IgA vasculitis / henoch schonlein purpura
				- purpura, abdominal pain, arthralgias, nephritis
				- IgA immune deposits in small vessels

		- diagnosis:
			- most common ideopathic GN
			- mean 25 yo, 4-80 yo
			- 65% of cases in 20s/30s
			- M:F = 2:1
			- ~30% of european glomerulopathies
			- ~45% of asian glomerulopathies
			- rare in patients of african descent

		- tx:
			- steroids
			- ACEi/ARBs


	- lupus nephritis:
		- pathology:
			- diffuse + global endocapillary proliferation
			- leukocyte/neutrophil infiltration
			- wire loop deposits thicken glomular walls
			- class IV: membranous lupus w/ spikes
			- EM + IF: subendothelial wire loop deposits at edge of GBM
			- IF: diffuse, global IgG glomular capillary wall
				- full house staining: IgG, IgM, IgA, C3 + C1

		- symptoms:
			- lymphadenopathy, malar rash
			- fever, athritis in multiple joints
			- urinalysis: 3+ proteinuria, RBCs
			- low complement, ANA positive, anti-DNA antibody positive


		- physiology:
			- immune complexes in mesangium + subendothelial

		- diagnosis:
			- staging:
				- I: minimal mesangial
				- II: mesangial proliferation
				- III: focal proliferation
				- IV: diffuse proliferation
				- V: membranous
				- VI: chronic sclerosing
		
		- tx:
			- class I + II: TU
			- class III + IV: steroids + immunosuppression
			- class V: only treat if heavy proteinuria
			- class VI: prep for transplant
			- belimumab: anti BLISS
			- voclosporin: calcineurin inhibitor
			- obinutuzumab: more potent version of rituximab


	- ANCA-associated nephritis:
		- pathology:
			- granulomatosis with polyangiitis (GPA): necrotizing + crescentic GN
			- silver stain: GBM rupture
			- EM: GBM rupture w/ no deposits
			- necrotizing arteritis: interlobular artery thickening + destruction of lumenal border
			- pulmonary capillaritis + alveolar hemorrhage
			- granulomatous inflammation

		- symptoms:
			- weight loss, sinusitis, malaise, dry cough
			- urinalysis: rbcs, wbcs, rbc casts
			- elevated Cr, normal complement, ANCA positive
			- cavitary lesion

		- physiology:
			- ANCAs are pathological

			- types:
				- pauci-immune:
					- usually w/ ANCA
					– granulomatosis with polyangiitis (GPA)
					– microscopic polyangiitis (MPA)

				- immune complex deposits (granular):
					- SLE 
		
		- diagnosis:
			- ANCA
		- tx: cyclophosphamide or rituximab + steroids


	- anti-GBM nephritis:
		- pathology:
			- silver stain: diffuse crescentic + necrotizing GN
			- trichrome: red circumferential crescent (fibrin)
			- IF: linear staining along GBM

		- symptoms:
		- physiology:
			- goodpasture's antigen: non-collagenous α3 domain in collagen IV
			- goodpasture's antigen exposed following:
				- hydrocarbon exposure
				- influenza
				- covid-19
			- goodpasture's antigen then targeted in GBM
		- diagnosis:
			- IgG
		- tx: steroids, cyclophosphamide, plasmapheresis 

	- glomerulonephritis complement levels:
		- low:
			- acute post-infectious GN
			- lupus nephritis
			- membranoproliferative GN (MPGN)
			- cryoglobulinemic GN

		- normal:
			- IgA nephropathy
			- ANCA-RPGN, microscopic polyangiitis (MPA), granulomatosis w/ polyangiitis (GPA)
			- anti-GBM disease
			- minimal change disease, FSGS, MGN
			- diabetes, amyloids, etc


L25: vascular & interstitial diseases I + II
	main:

	- tubulointerstitial disease:
		- acute tubular necrosis
			- hematuria, trace proteinuria
			- ischemic:
				- gross: P&S
				- tubular degenerative changes
				- most severe in PCT + mTAL
				- tx:
					- maintenace: dialysis
					- recovery: diuretic phase, often electrolyte abnormalities

			- nephrotoxic:
				- causes:
					- heavy metals, organic solvents
					- antiobitcs: gentamicin
					- antifungals: amphotericin B
					- antivirals: tenofovir disoproxil
					- chemo: cisplatin
					- bisphosphonate: zoledronate
					- radiation + radiocontrast
					- pigments: Hgb, Mgb
					- osmotic agents: mannitol


		- inflammatory: tubulointerstitial nephritis (TIN):
			- acute interstitial nephritis:
				- rash, fever, eosinophilia

			- chronic interstitial nephritis:

			- urinalysis: some rbcs, no casts, trace protein
			- Na wasting, unable to concentrate urine
			- urine acidication defect: hyperchloremic, metabolic acidosis
			- hyperkalemia

			- causes:
				- drug-induced 70%: antibiotics, PPIs, NSAIDs
				- inflammatory 20%: SLE, MCTD, fungal, mycobacteria, sarcoid etc
					-  ICIs
				- ideopathic 10%:

			- pathology:
				- eosinophils
				- interstitial inflammation + edema
				- tubulitis
				- +/- granulomas

			- elvated Cr, elevated BUN
			- tubulointerstitial nephritis

		- acure pyelonophritis:
			- acute suppurative infection of kidney
			- mostly unilateral: serum Cr stable

			- pathology:
				- gross: +/- coalescent absecesses
				- micro:
					- severe inflammation, PMNS
					- microabsecesses
					- PMN casts + tubulitis
				- hematogenous: starts cortically
				- ascending: starts near medulla
			- symptoms:
				- back pain, fever, pyuria
				- positive urine cultures / Ab sensitivity
			- infection:
				- ascending: UTI > hematogenous, F > M
				- hematogenous: septic emboli, bacteremia, F=M
				- 85% gram negative bacilli

		- chronic pyelonephritis:
			- scarring inflammation, deformity of calyces/pelvis
			- pathology:
				- gross: shrunken, irregular, flat scars, papillary blunting + calyceal deformity
				- micro: tubulointerstitial scarring, atrophic tubules + colloid casts
					- chronic inflammation, no PMNs
			- symptoms:
				- insidious RI
				- +/- htx, mild proteinuria, decreased Uosm, negative cultures
				- causes: VUR or persistent obstruction

		- papillary necrosis:
			- causes:
				- sickle cell
				- obstructive pyelonephritis
				- diabetes mellitus
				- analgesic abuse - phenacetin


L27: genetics I: cystic diseases
	main:
	- cystic diseases:
		- acquired:
			- simple renal cysts
		- hereditary:
			- adulthood (dominant):
				- autosomal dominant polycystic kidney disease (ADPKD)
					- 60% have positive hx
					- 50% ESRD by 60 yo
					- issue with cilia
					- genes:
						- PKD1 (85%) and PKD2 (15%) make proteins PC1/2
						- homozygotes -> lethal
						- trans-heterozygotes -> worse clinical course

					- common symptoms:
						- htx, pain, hematuria, polyuria
						- nephrolithiasis
						- low proteinuria
						- progressive GFR decline
						- hepatic cysts
						- cerebral/aortic aneurysms -> positive FHx stroke -> MR angio
						- colonic diverticula
					- tx:
						- ACEi/ARB
						- hematuria: analgesics + bed rest
						- fluoroquinolones
						- 
				- MCKD:
					- same as NPHP except adult onset + dominant
					- hyperuricemia + gout
					- genes:
						- MCKD1 / MUC1: 60s yo onset
						- MCKD1 / UMOD: 30s yo onset


			- childhood (recessive):
				- ARPKD
					- gene: PKHD1 (fibrocystin) -> dilation of renal/hepatic ducts
					- systemic htx
					- renal insuffiency
					- portal htx
					- potter syndrome:
						- flattened nose, infraorbital creases
						- pulmonary hypoplasia
				
				- nephronopthisis (NPHP):
					- most common cause of ESRD in children
					- NPHP genes
					-symptoms:
						- polyuria, polydipsia, secondary enuresis, anemia
						- senior-løken syndrome: retinitis pigmentosa
						- joubert syndrome: cerebellar vermis aplasia
						- liver fibrosis

	
L28: genetics II: glomerular diseases
	main:
	- alport's syndrome:
		- x-linked (80%): α5, α6
			- absence of α3, α4, α5 staining
			- deafness
			- opto issues

		- recessive (20%): α3, α4
			- less severe in carriers
			- FSGS in progressive disease
		
		- normal complement / serologies
		- microhematuria, proteinuria, renal dysfunction
		- collagen IV issue
		- tx:
			- ACEi/ARBs
			- transplant:
				- anti-GBM disease: antibodies against donor collagen

	- glomerular diseases:	
		- focal segmental glomerulosclerosis (FSGS):
			- monogenic: steroid resistant nephrotic syndrome, mutations in podocyte proteins
		- APOL1 increases risk
			- protects against sleeping sickness
			- 50%-80% increased risk of CKD

		- membranous nephropathy:
			- immune MN:
				- 70% have PLA2RI antibodies
				- HLA-PLA2R explains 1/3 of risk
			- IgA nephropathy:

	
L29: chronic kidney disease
	main:
	- CKD:
		- proteinuria associated with bad events
		- criteria (either):
			-  kidney damage > 3 months
				- albuminuria (>= 30mg/g)
				- Hx of transplant
				- abnormalities: electrolyte, histology 
			-  GFR < 60

		- stages:
			- 1: GFR > 90 diagnose, slow progressin
			- 2: GFR: 60 - 89
			- 3A: GFR: 45-59, treat complications
			- 3B: GFR: 30-44, 
			- 4: GFR: 15-29, nephro, prep for dialysis/transplant
			- 5: < 15, prep for dialysis/transplant
			- ESRD: < 15, on dialysis or had kidney transplant

		- causes:
			- primary:
				- vascular disease: RAS, htx, Sc, MAHA
				- glomerular disease: DM, glomerulonephritis
				- tubulo-interstitial disease: AIN, ATN, reflux, obstruction, cystic
			- secondary:
				- htx + RAAS activation -> inflammation -> renal hypertrophy
					- glomerulosclerosis + interstitial fibrosis
		
		- diagnosis:
			- biopsy, US
		- prerenal failure:
			- renal artery stenosis (RAS):
		- renal failure:
			- tubulointerstitial fibrosis
			- renal parenchymal volume loss
			- enlarged/small kidneys
			- obstruction
			- cystic disease
		- postrenal failure:
			- hydronephrosis
			- hydroureter
			- dilated calyces

		- anemia:
			- EPO deficiency
			- inflammation -> destruction of blasts, inhibit epo production / resistance
				- hepcidin upregulation
		- acidosis:
			- H2CO3 production failure
			- effects: muscle wasting, bone disease, inflammation, etc
		- uremia:
			- symptoms: fatigue, anorexia, nausea, mental slowing, pruritus
		- tx:
			- ACEi, ARBs
			- SGLT2i
			- manage htx



L30: calcium phosphate homeostasis
	main:
	- calcium phosphate homeostasis:
		- vitamin D pathway:
			- 7-dehydrocholesterol --(sun)--> vitamin D3
			- vitamin D --(liver)--> 25(OH)D
			- 25(OH)D --(kidney)--> 1,25(OH)2D
		- 1,25(OH)2D functions:
			- up regulates FGF-23
			- increases bone resorption
			- increases Ca + PO4 absorption
			- inhibits PTH
		- PTH functions:
			- increases PO4 excretion
			- increases 1,25(OH)2D production
		- FGF-23 functions:
			- decreases 1,25(OH)2D production
			- increases 1,25(OH)2D degradation
			- increases PO4 excretion

		- Ca/Phos function
			- decreases 1,25(OH)2D production

		- calcitriol function:
		 	- decreases 1,25(OH)2D production

		 - storage:
		 	- calcium stored in bones
	
	- calcium control:
		- PTH
		- PO4: reduces urine Ca, stimulates PTH
	- PO4 control:
		- FGF-23 (phosphatonin): controls reabsorption

	- CKD - mineral bone disorder:
		- reduced klotho expression -> reducded PO4 excretion
		- chronic PO4 retention
		- increased PTH -> parathyroid gland hyperplasia

		- renal osteodystrophy:
			- significant bone resorption with ckd

		- tx:
			- parathyroidectomy
			- vitamin D analogs:
				- ergocalciferol (D2)
				- cholecalciferol (D3)
					- reduces secondary hyperparathyroidism
				- active D:
					- alfacalcidol
					- paricalcitol
					- doxercalciferol
					- calcitriol
			- diet:
				- low phophate diet
					- reduction in dairy, beans, cereal
			- Pi binders:
				- calcium containing:
					- calcium carbonate (tums)
					- calcium acetate (phoslo)
				- non-calcium binders:
					- sevelamer: big tablets
					- lanthanum: not chewable
					- sucroferric oxyhydroxide: diarrhea
					- ferric citrate: diarrhea
					- aluminum oh: osteomalacia, dementia
			- calcium sensor stimulation:
				- lowers PTH, Ca, PO4
				- types: cinacalet, etelcalcetide

	
L31: nephrolithiasis
	main:
	- epidemiology:
		- 50% risk of second stone 5-7 years
		- 9% women, 20% men
		- hot weather worsens: sweat -> concentrating

	- stone types:
		- calcium oxalate (CaO):
			- risks: hypercalciuria, hyperuricosuria, hyperoxaluriam, low V, low Ucitrate, 
			- 70%
			- malabsorption, obesity
			- envelope appearance

		- calcium phosphate (CaP):
			- hypercalciuria, alkaline urine, medullary sponge kidney
			- coffin lid appearance

		- uric acid:
			- 10-15%
			- risks: acidic urine, metabolic syndrome, gout, hyperuricemia
			- diamond shape
			- detectable by RUS or CT

		- magnesium ammonium phosphate (struvite):
			- 10-15%
			- urine infection w/ urea splitting bacteria
				- proteus, haemophilus, klebsiella, ureaplasma urealyticum
			- staghorn stones
			- risk: women, chronic urinary obstruction, neuro dysfunction

		- cystine:
			- <1%
			- cystine, ornithine, arginine, lysine transporter defects
			- cystinuria
			- microhexagonal
			- CT or RUS

	- stone inhibitors:
		- Mg, citrate, tartrate, pyrophosphate, phosphocitrate
		- THP, GAGS, nephrocalcin, calgranulin, osteopontin, UPTF-1

	- diagnosis:
		- acute, colicky flank pain
		- hematuria
		- reccurent uti

	- states:
		- hypercalciuria: bone resorption, vitamin D excess, ideopathic
	
	- management:
		- medical:
			- 

			- drink more water
			- oxalate: diet restriction
			- Ca: thiazide diuretics, citrate helps, normal Ca diet

			- uric acid stones -> diet + allopurinol
			- cystine stones -> captopril: captopril-cystine complex more soluble
		- surgical:
			- Percutaneous Nephrolithotomy
			- Ureteroscopic removal
			- Extracorporeal Shock Wave Lithotripsy


L32: obstructive uropathy:
	main:
	- obstructive uropathy:
		- epediomiology:
			- 20-60 yo: occurence women > men
			- >60 yo: occurence men > women
			- congenital: occurence men > women
		- pathophysiology:
			- unilateral:
				- phase 1:
					- first hour
					- increased RBF by PGE2 + NO
					- tubule pressure high
				- phase 2:
					- 3-4 hours
					- decreased RBF by RAAS constriction
					- tubule pressure high
				- phase 3:
					- 5 hours
					- decreaed RBF
					- tubule pressure low

			- bilateral:
				- phase 1:
					- first 90 mins
					- increased RBF by PGE2 + NO
				- phase 2: decreased RBF

			- obstruction messes up gradients
			- gross changes:
				- 6 weeks: cystic dilation
			- microscopic changes:
				- 7 days: dilation of duct, tubules, bowmans space, edema
				- 12 days: papillary tip necrosis
				- 16 days: thickening of GBM
				- 5-6 weeks: glomerular collapse, interstitial fibrosis

			- common causes:
				- upper urinary tract:
					- nephrolithiasis
					- extrinsic
					- ureteropelvic junction obstuction
					- blood clot
				- lower urinary tract:
					- benign prostatic hyperplasia
					- urethral stricture
					- cervical cancer
					- uterine prolapse
					- pregnancy
		- diagnosis:
			- US, retrograde pyelography, CT, MRI, nuclear renography

		- management:
			- surgery: percutaneous fluoroscopic needle, endoscopic
			- stent

		- post obstructive diuresis:
			- only after bilateral obstruction
			- gradient lost after obstruction -> diuresis
			- 500-600 cc per hour for 24 hours
			- profound metabolic disarray + hypokalemia


L33: dialysis
	main:
	- uremic syndrome:
		- symptoms:
			- GI: anorexia, N/V, dysguesia, bleeds
			- skin: pruritis, uremic frost
			- CV: dyspnea, pericarditis
			- encephalopathy
			- myoclonus, asterixis

	- dialysis indications:
		- uremic syndrome
		- GFR < 5-10, 10-15 with LV CHF

	- adjuvant management:
		- dose adjustments
		- special diet
		- restriction of overhydration
	
	- dialysis:
		- requires EPO replacement
		- activated vitamin D
		- suppression of PTH
		- replace B complex

		- diffusion:
			- J = D * A * dC/dx
			- small molecule clearance
			- corrects electrolyte inbalance

		- convection:
			- solvent drag
			- ultrafiltrate solute concentration approximates original solvent
			- larger weight molecules
			- NaCL + H20 correction
	
		- hemodialysis:
			- goals:
				- nitrogen removal: diffusion
				- fluid/electrolyte balance:
					- convection for NaCL + H20
					- diffusion for rest
				- acid-base control: diffusion
			- 90-95% diffusion
			- hydrostatic pressure gradient
			- AV fistula / AV graft
			- risks: strict dietary limitations
			- 65% BUN reduction each treatment

		- peritoneal dialysis:
			- add dialysate into peritoneal space
			- 80-90% diffusion
			- osmotic pressure gradient
			- intra-abdominal catheter
			- risks: peritonitis, glycemic control, hernias, EPS
			- types:
				- CAPD: continuous ambulatory PD
				- APD: automated PD
				- CCPD: continuous cyuclic PD

		- mineral bone disorder:
			- use phosphate binders
	
L34: kidney transplantation basics
	main:
	- transplants have better survival
		- equalizes after 106 days
		- earlier, better survival

	- eligibility:
		- on dialysis or GFR <= 20
		- no contraindications
			- absolute:
				- malignancy
				- infection
				- contraindication to surgery
				- organ failure
			- relative:
				- substance abuse
				- insurance coverage
				- inadequate support
				- nonadherence
				- severe uncontrolled psychiatric illness
				- conditions that reduce allograft longevity

	- matching:
	 	- wait time:
			- dialysis start time or registration date (w/e earliest)
			- special: former living donor, pediatric, perfect match / highly sensitized
			- blood type
			- center
			- regional variation

		- match donor risk index: age, diabetes, height, cause of death, weight, Pcr, hep C, htx, race
		- HLA sensitized:
			- pregnancy, transfusion, transplant
			- PRA assessment
		- swaps / chains: untapped potential

	- transplant surgery/medications:
		- anterior placed in left lower abdomen
		- immunosuppression:
			- intense first week
				- lympho or non-lymphdepleting agent
				- steroids
			- maintenance:
				- calcineurin inhibitors: tacrolimus, cyclosporine
				- nucleotide synthesis inhibitors: MPA
				- mTOR inhibitors: sirolimus, everolimus
				- CD80 inhibitors: CTLA 4-Ig
				- cell cycle inhibitors: azathioprine
		- rejection:
			- acute:
				- 10-20% cases, 90% successful treatment
				- cell mediated: host cells infiltrate/kill graft
				- antibody mediated: antibodies destroy peri-tubular glomerular capillaries
			- chronic:
				- very common
	- death:
		- 40% fail due to patient death
		- 60% allografts fail:
			- 40% chronic rejection
			- 10-20% from other causes
	
L35: ESKD and transplant disparities
	main:
	- ESRD:
		- transplant is best option cost + outcome
		- covered by medicare
	- transplants:
		- black people are less likely to be referred, get it
		- APOL1 testing